Comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving and treatment abstinence in methamphetamine abusers
Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
Protocol summary
The aim of this study is comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving, recurrence and treatment abstinence in methamphetamine abusers.
The aim of this study is comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving, relapse and mental health in methamphetamine abusers.
The aim of this study is comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving, recurrencerelapse and treatment abstinencemental health in methamphetamine abusers.
هدف این مطالعه مقایسه تاثیر دو شیوه درمانی متیل فنیدیت و ترکیب ماتریکس- متیل فنیدیت بر شدت اعتیاد، ولع مصرف، عود و ماندگاری درمان در سوء مصرف کنندگان متامفتامین است.
هدف این مطالعه مقایسه تاثیر دو شیوه درمانی متیل فنیدیت و ترکیب ماتریکس- متیل فنیدیت بر شدت اعتیاد، ولع مصرف، عود و سلامت روان در سوء مصرف کنندگان متامفتامین است.
هدف این مطالعه مقایسه تاثیر دو شیوه درمانی متیل فنیدیت و ترکیب ماتریکس- متیل فنیدیت بر شدت اعتیاد، ولع مصرف، عود و ماندگاری درمانسلامت روان در سوء مصرف کنندگان متامفتامین است.
ولع مصرف و شدت اعتیاد (پیامدهای اولیه)
سلامت روان و عود مجدد (پیامدهای ثانویه)
ولع مصرف و شدت اعتیاد(پیامدهایاعتیاد (پیامدهای اولیه) ولع مصرف(پیامدهایسلامت روان و عود مجدد (پیامدهای ثانویه)
General information
Factorial
Parallel
factoparal
empty
The updating process was done before publishing the paper to correct the registration information.
The updating process was done before publishing the paper to correct the registration information.
empty
پروسه بروزرسانی قبل از انتشار مقاله به منظور تصحیح اطلاعات ثبت انجام گرفت.
پروسه بروزرسانی قبل از انتشار مقاله به منظور تصحیح اطلاعات ثبت انجام گرفت.
being at the age of 20 to 48 years
Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
the dominant use of methamphetamine for at least 3 months
being at the age of 20 to 48 years
Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
The dominant use of methamphetamine
Seeking treatment for methamphetamine abuse
being at the age of 20 to 48 years Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition theThe dominant use of methamphetamine Seeking treatment for at least 3 monthsmethamphetamine abuse
محدوده سنی 20 تا 48 سال
تشخيص وابستگی به متامفتامین برحسب معيارهاي راهنماي تشخيصي و آماري اختلالات رواني نسخه پنجم
مصرف غالب شيشه حداقل به مدت 3 ماه
محدوده سنی 20 تا 48 سال
تشخيص وابستگی به متامفتامین برحسب معيارهاي راهنماي تشخيصي و آماري اختلالات رواني نسخه پنجم
مصرف غالب شيشه
به دنبال درمان سوء مصرف متآمفتامین باشد
محدوده سنی 20 تا 48 سال تشخيص وابستگی به متامفتامین برحسب معيارهاي راهنماي تشخيصي و آماري اختلالات رواني نسخه پنجم مصرف غالب شيشه حداقل به مدت 3 ماهدنبال درمان سوء مصرف متآمفتامین باشد
Unwillingness to participate in the study
having severe psychotic disorders
Unwillingness to participate in the study
Having severe psychotic disorders
Suicide attempts within the past 12 months
Major cardiovascular disorder
Epilepsy
Current alcohol or sedative physical dependence or cocaine dependence
Unwillingness to participate in the study havingHaving severe psychotic disorders Suicide attempts within the past 12 months Major cardiovascular disorder Epilepsy Current alcohol or sedative physical dependence or cocaine dependence
عدم تمایل به شرکت در مطالعه
ابتلا به بيماري روانپزشكي شديد
عدم تمایل به شرکت در مطالعه
ابتلا به بيماري روانپزشكي شديد
اقدام به خودکشی در 12 ماه گذشته
اختلال عمده قلبی و عروقی
تشنج
در حال حاضر به الکل و یا آرام بخش ها وابستگی جسمی داشته باشد یا به کوکائین معتاد باشد
عدم تمایل به شرکت در مطالعه ابتلا به بيماري روانپزشكي شديد اقدام به خودکشی در 12 ماه گذشته اختلال عمده قلبی و عروقی تشنج در حال حاضر به الکل و یا آرام بخش ها وابستگی جسمی داشته باشد یا به کوکائین معتاد باشد
Random assignment will be done by the use of computer-generated random numbers.
Randomization will be performed with simple method and random numbers generated by computer software (Stat Trek software) which choose the random numbers.
Random assignmentRandomization will be doneperformed with simple method and random numbers generated by computer software (Stat Trek software) which choose the use of computer-generated random numbers.
تصادفی سازی با استفاده از اعداد تصادفی ایجاد شده توسط کامپیوتر انجام خواهد شد.
نحوه تصادفی سازی با روش ساده و استفاده از اعداد تصادفی ایجاد شده توسط نرم افزار کامپیوتری (نرم افزار Stat Trek) انجام خواهد شد. در اين روش كامپيوتر اعداد تصادفي انتخاب مي كند.
نحوه تصادفی سازی با روش ساده و استفاده از اعداد تصادفی ایجاد شده توسط کامپیوترنرم افزار کامپیوتری (نرم افزار Stat Trek) انجام خواهد شد. در اين روش كامپيوتر اعداد تصادفي انتخاب مي كند.
empty
empty
empty
empty
Primary outcomes
#1
Before intervention and 4, 8 and 12 weeks after intervention
At the beginning of the study and after 12 weeks of intervention
Before interventionAt the beginning of the study and 4, 8 andafter 12 weeks afterof intervention
قبل از مداخله و 4، 8 و 12هفته بعد از شروع مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
قبل از مداخلهدر ابتدای مطالعه و 4، 8 و 12هفته12 هفته بعد از شروع مداخله
شاخص شدت اعتیاد (ASI)
شاخص شدت اعتیاد
شاخص شدت اعتیاد (ASI)
#2
empty
Craving
Craving
empty
ولع مصرف
ولع مصرف
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Desire for Drug Questionnaire (DDQ craving)
Desire for Drug Questionnaire (DDQ craving)
empty
پرسشنامه DDQ
پرسشنامه DDQ
Secondary outcomes
#1
Craving
Mental health
CravingMental health
ولع مصرف
سلامت روان
ولع مصرفسلامت روان
Before intervention and 4, 8 and 12 weeks after intervention
At the beginning of the study and after 12 weeks of intervention
Before interventionAt the beginning of the study and 4, 8 andafter 12 weeks afterof intervention
قبل از مداخله و 4، 8 و 12هفته بعد از شروع مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
قبل از مداخلهدر ابتدای مطالعه و 4، 8 و 12هفته12 هفته بعد از شروع مداخله
Visual cues inducing craving
General Health Questionnaire (GHQ)
Visual cues inducing cravingGeneral Health Questionnaire (GHQ)
Before intervention and 3, 6, 9 and 12 weeks after intervention
Before intervention and 3, 6, 9 and 12 weeks after intervention
empty
قبل از مداخله و 3، 6، 9 و 12هفته بعد از شروع مداخله
قبل از مداخله و 3، 6، 9 و 12هفته بعد از شروع مداخله
empty
Methamphetamine urine test
Methamphetamine urine test
empty
تست سریع ادراری
تست سریع ادراری
Recruitment centers
#1
Name of recruitment center - English: Faraby Hospital Substance Dependency Clinic
Name of recruitment center - Persian: درمانگاه اعتیاد بیمارستان فارابی
Full name of responsible person - English: Nazanine Arian
Full name of responsible person - Persian: نازنین آرین
Street address - English: Isar square, Farabi hospital, Kermanshah
Street address - Persian: کرمانشاه، بلوار ایثار، بیمارستان فارابی
City - English: Kermanshah
City - Persian: کرمانشاه
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of recruitment center - English: Faraby Hospital Substance Dependency Clinic
Name of recruitment center - Persian: درمانگاه اعتیاد بیمارستان فارابی
Full name of responsible person - English: Nazanine Arian
Full name of responsible person - Persian: نازنین آرین
Street address - English: First floor, No. 7, Farabi Hospital, Isar Blvd., Kermanshah
Street address - Persian: کرمانشاه، بلوار ایثار، بیمارستان فارابی، پلاک7، طبقه اول
City - English: Kermanshah
City - Persian: کرمانشاه
Province: Kermanshah
Country: Iran (Islamic Republic of)
Postal code: 6719851451
Phone: +98 83 3826 4513
Fax:
Email: arian-n@kaums.ac.ir
Web page address:
Name of recruitment center - English: Faraby Hospital Substance Dependency Clinic Name of recruitment center - Persian: درمانگاه اعتیاد بیمارستان فارابی Full name of responsible person - English: Nazanine Arian Full name of responsible person - Persian: نازنین آرین Street address - English: Isar squareFirst floor, No. 7, Farabi hospitalHospital, Isar Blvd., Kermanshah Street address - Persian: کرمانشاه، بلوار ایثار، بیمارستان فارابی، پلاک7، طبقه اول City - English: Kermanshah City - Persian: کرمانشاه Province: Kermanshah Country: Iran (Islamic Republic of) Postal code: 6719851451 Phone: +98 83 3826 4513 Fax: Email: arian-n@kaums.ac.ir Web page address:
Sponsors / Funding sources
#1
contact.organization_id:
Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences
Name of organization / entity - Persian: معاونت پژوهشی دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Gholamali Hamidi
Full name of responsible person - Persian: غلامعلی حمیدی
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
contact.organization_id:
Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences
Name of organization / entity - Persian: معاونت پژوهشی دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Gholamali Hamidi
Full name of responsible person - Persian: غلامعلی حمیدی
Street address - English: Ghotbe Ravandi Boulevard, Kashan
Street address - Persian: کاشان، بلوار قطب راوندی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 8715988171
Phone: +98 31 5554 2999
Fax:
Email: hamidi_gh@kaums.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences Name of organization / entity - Persian: معاونت پژوهشی دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Gholamali Hamidi Full name of responsible person - Persian: غلامعلی حمیدی Street address - English: Ghotbe Ravandi Boulevard, Kashan Street address - Persian: کاشان، بلوار قطب راوندی City - English: Kashan City - Persian: کاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 8715988171 Phone: +98 31 5554 2999 Fax: Email: hamidi_gh@kaums.ac.ir Web page address:
Sharing plan
empty
Undecided - It is not yet known if there will be a plan to make this available
Undecided - It is not yet known if there will be a plan to make this available
empty
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست
هنوز تصمیم نگرفتهام - برنامه انتشار آن هنوز مشخص نیست
Protocol summary
Study aim
The aim of this study is comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving, relapse and mental health in methamphetamine abusers.
Design
In this research, 100 eligible patients with methamphetamine dependency diagnosis according to DSM-IV criteria are enrolled and a code was allocated to each one of them. Then, random assignment will be done by the use of computer-generated random numbers.
Settings and conduct
100 eligible patients methamphetamine abuse referred to Farabi Hospital affiliated to Kermanshah University of Medical Sciences, Kermanshah, Iran will be selected in the study. No blind design and factorial.
Participants/Inclusion and exclusion criteria
Inclusion criteria: methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders.
Exclusion criteria: Unwillingness to cooperate
Intervention groups
Patients will be divided into four treatment groups: matrix, methylphenidate, matrix-methylphenidate and control group. The first group (25 people) will be treated individuals, for 22 sessions of 45 minutes, twice a week for three months for matrix treatment. The second group (25 people) will receive methylphenidate 10 mg/day in the first month, 7.5 mg/day in the second month and 5 mg/day in the third month. The third group (25 people) matrix combination with methylphenidate and in the group control (25 people) there is no intervention.
Main outcome variables
Addiction severity and craving (primary outcomes)
Mental health and relapse (secondary outcome)
General information
Reason for update
The updating process was done before publishing the paper to correct the registration information.
Acronym
IRCT registration information
IRCT registration number:IRCT20171105037245N1
Registration date:2017-12-09, 1396/09/18
Registration timing:retrospective
Last update:2020-07-11, 1399/04/21
Update count:1
Registration date
2017-12-09, 1396/09/18
Registrant information
Name
Nazanin Arian
Name of organization / entity
Kashan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 83 3826 4513
Email address
arian-n@kaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Kashan University of Medical Sciences
Expected recruitment start date
2017-10-14, 1396/07/22
Expected recruitment end date
2017-11-13, 1396/08/22
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of two therapies methylphenidate and matrix-methylphenidate on the severity of addiction, craving and treatment abstinence in methamphetamine abusers
Public title
Comparison of the effect of two therapies methylphenidate and matrix-methylphenidate in methamphetamine abusers
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
being at the age of 20 to 48 years
Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
The dominant use of methamphetamine
Seeking treatment for methamphetamine abuse
Exclusion criteria:
Unwillingness to participate in the study
Having severe psychotic disorders
Suicide attempts within the past 12 months
Major cardiovascular disorder
Epilepsy
Current alcohol or sedative physical dependence or cocaine dependence
Age
From 20 years old to 48 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
100
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization will be performed with simple method and random numbers generated by computer software (Stat Trek software) which choose the random numbers.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Kashan University of Medical Sciences
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8715981151
Approval date
2017-10-12, 1396/07/20
Ethics committee reference number
IR.Kaums.REC.1396.59
Health conditions studied
1
Description of health condition studied
Methamphetamine Dependency
ICD-10 code
F15.15
ICD-10 code description
Other stimulant abuse with stimulant-induced psychotic disorder
Primary outcomes
1
Description
Addiction Severity
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Addiction Severity Index
2
Description
Craving
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Desire for Drug Questionnaire (DDQ craving)
Secondary outcomes
1
Description
Mental health
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
General Health Questionnaire (GHQ)
2
Description
Negative urine test for methamphetamine
Timepoint
Before intervention and 3, 6, 9 and 12 weeks after intervention
Method of measurement
Methamphetamine urine test
Intervention groups
1
Description
The Matrix program, which consists of 22 sessions of cognitive and behavioral psychotherapy, will be performed weekly in two sessions of forty five minutes for 12 weeks.
Category
Behavior
2
Description
Methylphenidate ( Ritalin ) will be given 10 mg per day in first month, 7.5 mg per day for second month and 5 mg per day for third month
Category
Treatment - Drugs
3
Description
Combining matrix and methylphenidate treatment (The Matrix program, which consists of 22 sessions of cognitive and behavioral psychotherapy, will be performed weekly in two sessions of forty five minutes for 12 weeks and methylphenidate ( Ritalin ) will be given 10 mg per day in first month, 7.5 mg per day for second month and 5 mg per day for third month)
Category
Treatment - Other
4
Description
Control group (not receiving any psychological educational services and drugs)
Category
N/A
Recruitment centers
1
Recruitment center
Name of recruitment center
Faraby Hospital Substance Dependency Clinic
Full name of responsible person
Nazanine Arian
Street address
First floor, No. 7, Farabi Hospital, Isar Blvd., Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6719851451
Phone
+98 83 3826 4513
Email
arian-n@kaums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Vice chancellor for research, Kashan University of Medical Sciences
Full name of responsible person
Gholamali Hamidi
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8715988171
Phone
+98 31 5554 2999
Email
hamidi_gh@kaums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Kashan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Abdollah Omidi
Position
PhD of Clinical Psychology
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 2999
Fax
Email
omidi-a@kums.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Abdollah Omidi
Position
PhD of Clinical Psychology
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
Ghotbe Ravandi Boulevard, Kashan
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 2999
Fax
Email
omidi-a@kums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Abdollah Omidi
Position
PhD of Clinical Psychology
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
Ghotbe Ravandi Boulevard, Kashan
City
kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 2999
Fax
Email
omidi-a@kums.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available